Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metoclopramide versus erythromycin for aspiration pneumonia prevention in mechanically ventilated ICU patients
IRCT20230618058512N1Phase 3Completed
- Sponsor
- Vice-Chancellery for Research, Hormozgan University of Medical Sciences
- Start
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in aspiration pneumonia comparing Metoclopramide with Erythromycin (2 arms). Primary endpoint: Aspiration pneumonia rate. Started Jul 2023; status: completed.
02
Drugs
metoclopramideerythromycin
03
Conditions
aspiration pneumonia
Beyond the preview
Go deeper on IRCT20230618058512N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230618058512N1.